Cargando…

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is one of the most lethal malignancies in the urinary system and the existing immunotherapy has not achieved satisfactory outcomes. Therefore, this study aims at establishing a novel gene signature for immune infiltration and clinical outcome (over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Daojia, Shi, Jian, Xiong, Zhiyong, Xiao, Wen, Meng, Xiangui, Lv, Qingyang, Xie, Kairu, Yang, Hongmei, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822671/ https://www.ncbi.nlm.nih.gov/pubmed/35135552 http://dx.doi.org/10.1186/s12935-022-02480-7

Ejemplares similares

HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress
por: Shi, Jian, et al.
Publicado: (2021)

ENO2 as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Shi, Jian, et al.
Publicado: (2023)

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
por: Tan, Diaoyi, et al.
Publicado: (2023)

Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia
por: Xie, Kairu, et al.
Publicado: (2021)

N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway
por: Miao, Daojia, et al.
Publicado: (2023)

Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression
por: Meng, Xiangui, et al.
Publicado: (2020)

Impact of inflammation and immunotherapy in renal cell carcinoma
por: Shi, Jian, et al.
Publicado: (2020)

The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling
por: Shi, Jian, et al.
Publicado: (2023)

RUFY3 and RUFY4 are ARL8 effectors that promote coupling of endolysosomes to dynein-dynactin
por: Keren-Kaplan, Tal, et al.
Publicado: (2022)

Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition
por: Yuan, ChangFei, et al.
Publicado: (2020)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

The B7H4-PDL1 classifier stratifies immuno-phenotype in cervical cancer
por: Chen, Lingyan, et al.
Publicado: (2022)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
por: Zhang, Jin, et al.
Publicado: (2020)

PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion
por: Wang, G, et al.
Publicado: (2015)

A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma
por: Jiang, Wen, et al.
Publicado: (2019)

Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma
por: Zhang, Xiaoqin, et al.
Publicado: (2021)

Rufi Ephesii De Renum et Vesicae Morbis
por: Nutton, Vivian
Publicado: (1978)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease
por: Nakken, Sigrid, et al.
Publicado: (2021)

Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)
por: Wu, Hua-Hui, et al.
Publicado: (2021)

SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma
por: Shang, Xiaoling, et al.
Publicado: (2021)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)

Abnormal expression and prognostic significance of EPB41L1 in kidney renal clear cell carcinoma based on data mining
por: Liang, Taotao, et al.
Publicado: (2020)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma
por: Jiang, Yuanbin, et al.
Publicado: (2020)

Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks
por: Wang, Yi, et al.
Publicado: (2021)

Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma
por: Zhang, Di, et al.
Publicado: (2020)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

ERK-mediated autophagy promotes inactivated Sendai virus (HVJ-E)-induced apoptosis in HeLa cells in an Atg3-dependent manner
por: Wang, Tao, et al.
Publicado: (2018)

Potential diagnostic and prognostic value and regulatory relationship of long noncoding RNA CCAT1 and miR-130a-3p in clear cell renal cell carcinoma
por: Jing, Jingjing, et al.
Publicado: (2021)

RUFY, Rab and Rap Family Proteins Involved in a Regulation of Cell Polarity and Membrane Trafficking
por: Kitagishi, Yasuko, et al.
Publicado: (2013)

Hypoxia promotes colorectal cancer cell migration and invasion in a SIRT1-dependent manner
por: Yu, Shentong, et al.
Publicado: (2019)

Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma
por: Stenzel, Philipp J., et al.
Publicado: (2019)

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population
por: Zhao, Qiang, et al.
Publicado: (2020)

Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach
por: Chen, Yongsheng, et al.
Publicado: (2016)

Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
por: Zhang, Zedan, et al.
Publicado: (2020)

Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma
por: Wang, Song, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jusbfef4t626396bj577dlae7